GENERIC NAME OF THE MEDICINAL PRODUCT:
B. Olmesartan Medoxomil + Amlodipine + Chlorthalidone Tablets (20mg+5mg+12.5mg) <
C. Olmesartan Medoxomil + Amlodipine + Chlorthalidone Tablets (40mg+5mg+6.25mg)
D. Olmesartan Medoxomil + Amlodipine + Chlorthalidone Tablets (40mg+5mg+12.5mg)
QUALITATIVE AND QUANTITATIVE COMPOSITION:
Each film coated tablet contains:
Olmesartan Medoxomil IP…………….20mg
Amlodipine Besylate IP
Equivalent to Amlodipine……………….5mg
Chlorthalidone IP……………………………6.25mg
Colours: Ferric Oxide Red USP-NF
& Ferric Oxide Yellow USP-NF
B) Olmesartan Medoxomil + Amlodipine + Chlorthalidone Tablets (20mg+5mg+12.5mg)
Each film coated tablet contains:
Olmesartan Medoxomil IP…………….20mg
Amlodipine Besylate IP
Equivalent to Amlodipine……………….5mg
Chlorthalidone IP……………………………12.5mg
Colour: Sunset Yellow FCF
C) Olmesartan Medoxomil + Amlodipine + Chlorthalidone Tablets (40mg+5mg+6.25mg)
Each film coated tablet contains:
Olmesartan Medoxomil IP…………….40mg
Amlodipine Besylate IP
Equivalent to Amlodipine……………….5mg
Chlorthalidone IP……………………………6.25mg
Colours: Ferric Oxide Yellow USP-NF
D) Olmesartan Medoxomil + Amlodipine + Chlorthalidone Tablets (40mg+5mg+12.5mg)
Each film coated tablet contains:
Olmesartan Medoxomil IP…………….40mg
Amlodipine Besylate IP
Equivalent to Amlodipine……………….5mg
Chlorthalidone IP……………………………12.5mg
Colours: Titanium Dioxide IP
THERAPEUTIC INDICATIONS:
CAUTION & SCHEDULE:
KEEP MEDICINE OUT OF REACH OF CHILDREN.
Tablet to be swallowed as a whole, and not to be chewed or crushed.
SCHEDULE: SCHEDULE H PRESCRIPTION DRUG CAUTION: Not to be sold by retail without the prescription of a Registered Medical Practitioner.
SCHEDULE: SCHEDULE G PRESCRIPTION DRUG CAUTION: It is dangerous to take this preparation except under medical supervision.
STORAGE & DOSAGE:
Store in cool, dry & dark place.
Protect from Light & moisture.
Dosage: As directed by the Physician
Olmesartan Medoxomil + Amlodipine + Chlorthalidone Tablets (40mg+5mg+12.5mg) Technical Specification:
| Product Name: | Olmesartan Medoxomil + Amlodipine + Chlorthalidone Tablets |
| Brand Name: | Generic |
| Strength: | (20mg+5mg+6.25mg), (20mg+5mg+12.5mg), (40mg+5mg+6.25mg), (40mg+5mg+12.5mg) |
| Dosage Form: | Tablets (film coated) |
| Route of Administration: | Via Oral Route |
| Packing: | 10 Blister strips of 10 Tablets Each |
| Pack Insert/Leaflet: | PIL (Patient Information Leaflet) |
| Regulatory Documents: | COA, MOA, Stability Studies, GMP |
| Therapeutic use: | Antihypertensive |
| Indication: | Olmesartan Medoxomil+ Amlodipine+ Chlorthalidone is used in the treatment of Hypertension (high blood pressure).They work by widening and relaxing the blood vessels, thereby lowering blood pressure. Chlorthalidone is a diuretic which removes extra water and certain electrolytes from the body through urine. Over time it also works by relaxing blood vessels and improving blood flow. |
| Storage: | Store at temperature not exceeding 30℃. Store in cool, dry & dark place. Protect from Light & moisture. |
GENERIC NAME OF THE MEDICINAL PRODUCT:
- Olmesartan Medoxomil + Amlodipine + Chlorthalidone Tablets (40mg+5mg+12.5mg)
QUALITATIVE AND QUANTITATIVE COMPOSITION:
- Olmesartan Medoxomil + Amlodipine + Chlorthalidone Tablets (40mg+5mg+12.5mg)
Each film coated tablet contains:
Olmesartan Medoxomil IP…………….40mg
Amlodipine Besylate IP
Equivalent to Amlodipine……………….5mg
Chlorthalidone IP………………………..12.5mg
Colours: Titanium Dioxide IP
THERAPEUTIC INDICATIONS:
Olmesartan Medoxomil+ Amlodipine+ Chlorthalidone is used in the treatment of Hypertension (high blood pressure).They work by widening and relaxing the blood vessels, thereby lowering blood pressure. Chlorthalidone is a diuretic which removes extra water and certain electrolytes from the body through urine. Over time it also works by relaxing blood vessels and improving blood flow.
CAUTION & SCHEDULE:
CAUTION: Read enclosed leaflet before use.
Keep medicine out of reach of children.
Tablet to be swallowed as a whole, and not to be chewed or crushed.
SCHEDULE: SCHEDULE H PRESCRIPTION DRUG CAUTION: Not to be sold by retail without the prescription of a Registered Medical Practitioner.
SCHEDULE: SCHEDULE G PRESCRIPTION DRUG CAUTION: It is dangerous to take this preparation except under medical supervision.
STORAGE & DOSAGE:
Storage: Store at temperature not exceeding 30℃.
Store in cool, dry & dark place.
Protect from Light & moisture.
Dosage: As directed by the Physician.
Introduction to Olmesartan Medoxomil + Amlodipine + Chlorthalidone Tablets (40mg+5mg+12.5mg)
Olmesartan Medoxomil + Amlodipine + Chlorthalidone Tablets (40mg+5mg+12.5mg) are a triple-drug combination used to manage hypertension (high blood pressure) efficiently. With over 1.3 billion people worldwide affected by high blood pressure, effective antihypertensive therapy is in high global demand.
-
Olmesartan Medoxomil (40mg): An angiotensin receptor blocker (ARB) that relaxes blood vessels and lowers vascular resistance.
-
Amlodipine (5mg): A calcium channel blocker (CCB) that dilates arteries and improves blood flow.
-
Chlorthalidone (12.5mg): A thiazide-like diuretic that eliminates excess fluid and electrolytes through urine, supporting long-term blood pressure management.
Taj Pharma, a trusted manufacturer, exporter, and supplier from Vapi, Gujarat, India, guarantees high-quality, pure tablets suitable for global markets.
Uses and Benefits
Therapeutic Uses
-
Management of high blood pressure
-
Treatment of resistant hypertension
-
Prevention of stroke, heart attacks, and cardiovascular complications
-
Supports kidney and heart health
Key Benefits
-
Triple-action therapy reduces pill burden
-
Enhances patient compliance and adherence
-
Safe for long-term use under physician supervision
-
Provides effective blood pressure control
The global demand for effective antihypertensive combinations makes this product highly sought-after, especially in Asia, Africa, the Middle East, and Latin America.
Mechanism of Action
The combination works synergistically to control hypertension:
-
Olmesartan Medoxomil: Blocks angiotensin II receptors → relaxes arteries → reduces blood pressure
-
Amlodipine: Reduces calcium influx → dilates blood vessels → improves circulation
-
Chlorthalidone: Promotes urination → decreases plasma volume → lowers blood pressure
This multi-targeted approach ensures comprehensive blood pressure control and reduces cardiovascular risks effectively.
Dosage and Administration
-
Dosage Form: Tablets (40mg + 5mg + 12.5mg)
-
Recommended Dose: As per physician guidance
-
Administration: Oral, same time daily, with or without food
-
Monitoring: Regular checks for blood pressure, kidney function, electrolytes, and liver enzymes
Consistent use ensures optimal therapeutic outcomes while minimizing potential side effects.
Side Effects and Safety Information
Common Side Effects:
-
Headache, dizziness, palpitations, sleepiness
-
Visual disturbances, gastrointestinal issues
-
Muscle cramps, joint inflammation, peripheral edema
Serious Side Effects:
-
Electrolyte imbalance
-
Elevated liver enzymes, blood urea
-
Increased creatine phosphokinase (CPK)
-
Postural hypotension, impotence
Precautions:
-
Rise slowly from sitting/lying positions to prevent dizziness
-
Monitor kidney and liver function regularly
-
Consult a doctor if pregnant, breastfeeding, or with existing heart/kidney conditions
Trusted Manufacturer, Supplier, and Exporter
Taj Pharma Ltd., Vapi, Gujarat, is the leading Olmesartan Medoxomil + Amlodipine + Chlorthalidone Tablets (40mg+5mg+12.5mg) manufacturer in India.
State-of-the-Art Manufacturing Facilities
-
Advanced automated production lines adhering to WHO-GMP and EU-GMP standards
-
Stringent quality control measures
-
Contamination-free production environment
Quality Assurance
-
Compliance with IP, BP, USP standards
-
Batch-to-batch consistency and stability testing
-
Potency and purity verification
Affordable Pricing
-
Premium quality at competitive international prices
-
Cost-effective solutions without compromising quality
Global Presence
-
Exporting to over 40 countries worldwide
-
Reliable logistics and supply chain management
-
Assistance with customs and regulatory documentation
PCD Pharma Franchise Opportunities
-
Domestic and international distribution partnerships
-
Custom branding and private labeling options
-
Flexible distribution and support
In-Depth Details for Importers and Exporters
Taj Pharma offers comprehensive support for global buyers:
Regulatory Documentation
-
Certificate of Analysis (CoA)
-
Drug Master File (DMF)
-
CTD Dossier
-
WHO-COPP Certificate
-
Free Sale Certificate (FSC)
Custom Packaging & Labeling
-
Blister packs, strip packs, Alu-Alu packaging
-
Multi-language labeling for international compliance
-
Private labeling and branding available
Shelf-Life, Storage, and Dosage Form
-
Shelf-Life: 24–36 months
-
Storage: Cool, dry place away from sunlight
-
Dosage Form: Tablet (40mg + 5mg + 12.5mg)
Export Certifications
-
WHO-GMP, EU-GMP
-
ISO 9001:2015
-
COPP and CTD Dossier
Target Export Markets
-
Asia: Bangladesh, Nepal, Sri Lanka, Philippines
-
Africa: Nigeria, Kenya, South Africa, Ghana
-
Middle East: UAE, Saudi Arabia, Iraq
-
Europe & Latin America: Portugal, Chile, Argentina
Why is the Most Trusted Manufacturer and Exporter
State-of-the-Art Manufacturing
-
Automated, precision-driven production lines
-
Uniform quality across batches
Affordable Pricing & Quality Assurance
-
Premium quality at competitive rates
-
Certified and validated production processes
Global Presence & Supply Chain Support
-
Timely delivery and logistics
-
Assistance with customs and documentation
Top Exporting Countries
Nigeria, Kenya, South Africa, Vietnam, Philippines, Iraq, Libya, Uzbekistan, Ghana, Ethiopia, Yemen, Tanzania, Sri Lanka, Afghanistan, Myanmar, Nepal, Kazakhstan, Ecuador, Bangladesh, Dominican Republic
Technical Product Specification Table
| Product Name | Olmesartan Medoxomil + Amlodipine + Chlorthalidone Tablets (40mg+5mg+12.5mg) |
|---|---|
| Dosage Form | Tablets |
| Composition | Olmesartan 40mg + Amlodipine 5mg + Chlorthalidone 12.5mg |
| Therapeutic Category | Anti-hypertensive combination therapy |
| Indications | Hypertension management |
| Manufacturer | Taj Pharma Ltd., Vapi, Gujarat, India |
| Shelf Life | 24–36 months |
| Certifications | WHO-GMP, EU-GMP, ISO 9001:2015 |
| Packaging | Blister packs, strip packs, Alu-Alu packs |
| Storage | Cool, dry, away from sunlight |
| Regulatory Documents | COPP, CTD Dossier, CoA, FSC, DMF |
| Export Regions | Asia, Africa, Middle East, Latin America |
| Brand Options | OEM, private label, PCD franchise |
Call to Action for Buyers & Distributors
Distributors, importers, and PCD partners seeking Olmesartan Medoxomil + Amlodipine + Chlorthalidone Tablets (40mg+5mg+12.5mg) can contact Taj Pharma Ltd., Vapi, Gujarat, India. Partner with a WHO-GMP certified manufacturer offering high-quality tablets, competitive pricing, and reliable global supply.
📍 Address: Taj Pharma India Ltd., Vapi, Gujarat, India
🌐 Website: www.tajpharma.in
📧 Email: info@tajpharma.com
📞 Phone: +91 84484 44095 (Gen. Enq. 01)
Olmesartan Medoxomil + Amlodipine + Chlorthalidone Tablets (40mg+5mg+12.5mg)
-
What is this combination used for?
Management of high blood pressure and prevention of cardiovascular events. -
Who manufactures it?
Taj Pharma Ltd., Vapi, Gujarat, India. -
Is it WHO-GMP certified?
Yes, fully certified. -
Common side effects?
Dizziness, headache, palpitations, muscle cramps, urinary issues. -
Serious side effects?
Electrolyte imbalance, elevated liver enzymes, postural hypotension. -
Can children take it?
Only under strict physician supervision. -
How should it be taken?
Orally, once daily at the same time. -
PCD franchise available?
Yes, for domestic and international markets. -
Shelf-life?
24–36 months. -
Packaging options?
Blister packs, strip packs, Alu-Alu packs, private labeling. -
Export regions?
Asia, Africa, Middle East, Europe, Latin America. -
Storage conditions?
Cool, dry place away from sunlight. -
Can it be combined with other antihypertensives?
Only under doctor supervision. -
Precautions?
Monitor blood pressure, kidney function, electrolytes. -
Does it cause dizziness?
Yes, especially when standing quickly. -
Can pregnant women take it?
Consult a doctor first. -
How long before effects are seen?
Blood pressure reduction may occur within 1–2 weeks. -
Private labeling available?
Yes, Taj Pharma offers full private labeling support. -
Regulatory documentation provided?
Yes – CoA, DMF, CTD, COPP, FSC. -
Missed dose guidance?
Take as soon as remembered; do not double the next dose.






